nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension
|
Giorgi, Gabriele |
|
1988 |
116 |
6P2 |
p. 1801-1805 5 p. |
artikel |
2 |
A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension
|
Taylor, Stanley H. |
|
1988 |
116 |
6P2 |
p. 1820-1825 6 p. |
artikel |
3 |
A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension
|
Nechwatal, Walter |
|
1988 |
116 |
6P2 |
p. 1806-1814 9 p. |
artikel |
4 |
A multicenter study of doxazosin in the treatment of severe essential hypertension
|
Soltero, Ivan |
|
1988 |
116 |
6P2 |
p. 1767-1771 5 p. |
artikel |
5 |
A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy
|
Englert, Rudolf Georg |
|
1988 |
116 |
6P2 |
p. 1826-1832 7 p. |
artikel |
6 |
A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus
|
Castrignano, Rocco |
|
1988 |
116 |
6P2 |
p. 1778-1784 7 p. |
artikel |
7 |
Clinical experience with doxazosin in general medical practice
|
Rosenthal, Julian |
|
1988 |
116 |
6P2 |
p. 1748-1757 10 p. |
artikel |
8 |
Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: A one-year, double-blind study in 228 hypertensive patients
|
Talseth, Tore |
|
1988 |
116 |
6P2 |
p. 1790-1796 7 p. |
artikel |
9 |
Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy
|
Rosenthal, Julian |
|
1988 |
116 |
6P2 |
p. 1763-1766 4 p. |
artikel |
10 |
Doxazosin: A newly developed, selective α 1-inhibitor in the management of patients with pheochromocytoma
|
Miura, Yukio |
|
1988 |
116 |
6P2 |
p. 1785-1789 5 p. |
artikel |
11 |
Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice
|
van den Hogen, Arie L.C.J. |
|
1988 |
116 |
6P2 |
p. 1757-1762 6 p. |
artikel |
12 |
Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency
|
Bartels, Alien C.C. |
|
1988 |
116 |
6P2 |
p. 1772-1777 6 p. |
artikel |
13 |
Doxazosin versus atenolol: A randomized comparison of calculated coronary heart disease risk reduction
|
Mazzola, Carlo |
|
1988 |
116 |
6P2 |
p. 1797-1801 5 p. |
artikel |
14 |
Effects of antihypertensives on plasma lipids and lipoprotein metabolism
|
Krone, Wilhelm |
|
1988 |
116 |
6P2 |
p. 1729-1734 6 p. |
artikel |
15 |
Implications of doxazosin therapy on risk of coronary heart disease
|
Hansson, Lennart |
|
1988 |
116 |
6P2 |
p. 1832-1837 6 p. |
artikel |
16 |
Introduction
|
Hayduk, Karl |
|
1988 |
116 |
6P2 |
p. 1707- 1 p. |
artikel |
17 |
Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: The effects of antihypertensive agents
|
Dzau, Victor J. |
|
1988 |
116 |
6P2 |
p. 1725-1728 4 p. |
artikel |
18 |
Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction
|
Taylor, Stanley H. |
|
1988 |
116 |
6P2 |
p. 1735-1747 13 p. |
artikel |
19 |
Review of major intervention studies in hypertension and hyperlipidemia: Focus on coronary heart disease
|
Middeke, Martin |
|
1988 |
116 |
6P2 |
p. 1708-1712 5 p. |
artikel |
20 |
Summary and closing remarks
|
Hayduk, Karl |
|
1988 |
116 |
6P2 |
p. 1838-1840 3 p. |
artikel |
21 |
The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine
|
Lindner, Udo K. |
|
1988 |
116 |
6P2 |
p. 1814-1820 7 p. |
artikel |
22 |
The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease
|
Assmann, Gerd |
|
1988 |
116 |
6P2 |
p. 1713-1724 12 p. |
artikel |